ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

DRRX Durect Corp

0.914
-0.0019 (-0.21%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 104,084
Bid Price 0.8603
Ask Price 0.9684
News -
Day High 0.9659

Low
0.4703

52 Week Range

High
7.46

Day Low 0.926
Share Name Share Symbol Market Stock Type
Durect Corp DRRX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0019 -0.21% 0.914 17:00:42
Open Price Low Price High Price Close Price Previous Close
0.9266 0.926 0.9659 0.9313 0.9159
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
318 104,084 US$ 0.9404904 US$ 97,890 - 0.4703 - 7.46
Last Trade Type Quantity Price Currency
16:27:51 formt 331 US$ 0.914 USD

Durect Corp Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
28.04M 29.83M - 8.55M -27.62M -0.93 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Durect News

Date Time Source News Article
3/27/202415:01PR Newswire (US)DURECT Corporation Reports Fourth Quarter and Full Year 2023..
3/20/202415:30PR Newswire (US)DURECT Corporation to Announce Fourth Quarter and Full Year..
3/04/202410:37Edgar (US Regulatory)Form 8-K - Current report
3/04/202406:00PR Newswire (US)DURECT and Charles River Laboratories Enter into..
2/14/202415:16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
2/07/202417:48PR Newswire (US)DURECT Corporation to Present at the Oppenheimer 34th Annual..
12/22/202315:15Edgar (US Regulatory)Form 8-K - Current report
12/01/202315:28Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
11/13/202315:15Edgar (US Regulatory)Form 8-K - Current report
11/13/202315:05PR Newswire (US)DURECT Corporation Reports Third Quarter 2023 Financial..
11/09/202315:30PR Newswire (US)DURECT Corporation to Announce Third Quarter 2023 Financial..
11/07/202315:10Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No DRRX Message Board. Create One! See More Posts on DRRX Message Board See More Message Board Posts

Historical DRRX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.90980.96590.80010.867275875,0280.00420.46%
1 Month1.231.230.72350.9127271115,059-0.316-25.69%
3 Months0.851.440.68021.01164,0750.0647.53%
6 Months2.343.140.47030.8004787458,566-1.43-60.94%
1 Year4.257.460.47031.73344,405-3.34-78.49%
3 Years17.7019.300.47036.97472,782-16.79-94.84%
5 Years5.87341.000.470315.41796,187-4.96-84.44%

Durect Description

Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the United States.

Your Recent History

Delayed Upgrade Clock